Position in AMGN
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$10,684,350
+$1,558,417 QoQ
Shares Held
29,505
+13.8% QoQ
Ownership
0.005%
of shares outstanding
% of Portfolio
0.06%
of 13F equity value
Holder Rank
#527
of 3,140 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in AMGN Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026BROWN BROTHERS HARRIMAN & CO holds $677,640,956 across 15 Drug Manufacturers - General names. AMGN ranks #5 (1.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
275,383 | $330,302,659 | |
| 2 | JNJ |
Johnson & Johnson
|
953,567 | $242,177,410 | |
| 3 | MRK |
Merck & Co., Inc.
|
257,653 | $33,108,410 | |
| 4 | ABBV |
AbbVie Inc.
|
127,844 | $32,170,664 | |
| 5 | AMGN |
Amgen Inc
This page
|
29,505 | $10,684,350 | |
| 6 | NVS |
Novartis AG
|
50,794 | $7,960,435 | |
| 7 | PFE |
Pfizer Inc
|
327,905 | $7,895,952 | |
| 8 | BMY |
Bristol Myers Squibb Co
|
97,895 | $5,640,709 |
All Filings in AMGN
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $10,684,350 | 29,505 | Shares | Sole | 2026-08-12 | |
| 2026-03-31 | $9,125,933 | 25,937 | Shares | Sole | 2026-05-14 | |
| 2025-12-31 | $6,704,618 | 20,484 | Shares | Sole | 2026-02-12 | |
| 2025-09-30 | $5,053,355 | 17,907 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $5,191,351 | 18,593 | Shares | Sole | 2025-08-11 | |
| 2025-03-31 | $5,473,310 | 17,568 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $4,742,605 | 18,196 | Shares | Sole | 2025-02-12 | |
| 2024-09-30 | $6,570,828 | 20,393 | Shares | Sole | 2024-11-13 | |
| 2024-06-30 | $6,390,227 | 20,452 | Shares | Sole | 2024-08-09 | |
| 2024-03-31 | $4,804,155 | 16,897 | Shares | Sole | 2024-05-10 | |
| 2023-12-31 | $4,797,261 | 16,656 | Shares | Sole | 2024-02-12 | |
| 2023-09-30 | $4,433,196 | 16,495 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $3,678,649 | 16,569 | Shares | Sole | 2023-08-07 | |
| 2023-03-31 | $3,995,644 | 16,528 | Shares | Sole | 2023-05-11 | |
| 2022-12-31 | $4,385,300 | 16,697 | Shares | Sole | 2023-02-09 | |
| 2022-09-30 | $3,961,855 | 17,577 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $4,388,158 | 18,036 | Shares | Sole | 2022-08-11 | |
| 2022-03-31 | $4,124,240 | 17,055 | Shares | Sole | 2022-05-13 | |
| 2021-12-31 | $3,802,667 | 16,903 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $3,428,130 | 16,121 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $4,188,600 | 17,184 | Shares | Sole | 2021-08-13 | |
| 2021-03-31 | $4,382,539 | 17,614 | Shares | Sole | 2021-05-13 | |
| 2020-12-31 | $4,061,076 | 17,663 | Shares | Sole | 2021-02-16 | |
| 2020-09-30 | $4,004,799 | 15,757 | Shares | Sole | 2020-11-16 | |
| 2020-06-30 | $3,867,868 | 16,399 | Shares | Sole | 2020-08-13 | |
| 2020-03-31 | $2,430,732 | 11,990 | Shares | Sole | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||